Study information for Diabetes Trials

The Value of Clinical Research
At the Dallas Diabetes and Endocrine Center we are continually conducting numerous clinical trials specifically designed to treat patients with Type 1 and 2 Diabetes. Each trial is unique in its objectives and type of medications that are being used, but all strive for the ultimate goal of lowering blood sugars. Some of our previous studies include research of the following marketed drugs for the treatment of diabetes: Glucophage and Fortamet (metformin), Diabeta (glyburide), Amaryl (glimepiride), Actos (pioglitizone), Avandia (rosiglitizone) and many of the combination medications such as Metaglip, Glucovance, Avandamet, Avandaryl and ACTOplus met. We have also conducted trials in a new class of diabetes treatment which includes Byetta. In addition, we have completed extensive research in all types of insulins such as Humalog, Novolog, 70/30, 75/25, 50/50, Lantus, Levemir and the Inhaled Insulins.

In addition to medication specifically to assist you in lowering your blood sugar levels, we also conduct trials for the treatment of some complications of diabetes such as Neuropathy (numbness and/or pain in feet) and Nephropathy (a decrease in kidney function). Please contact our office at 972-566-5678 to learn about all of our ongoing efforts to improve your life with diabetes.
ON THE CUTTING EDGE - NEW TREATMENTS FOR DIABETES
The medications listed below were all researched at our site prior to being released on the market. These are the recent additions to the treatment of Diabetes.

BYETTA (bye-A-tuh) is the first in a class of medicines for type 2 diabetes called incretin mimetics. BYETTA is an injectable medicine used to improve glucose (blood sugar) control in adults with type 2 diabetes. Although it is injectible, it is not insulin. It can be used with oral medications.

To learn more about Byetta, visit http://www.byetta.com/index.jsp


EXUBERA - In the fall of 2006, Pfizer marketed the first Inhaled Insulin that was studied for over 10 years at our research center. In October 2007, Pfizer announced the discontinuation of producing the inhaled insulin.

For more information regarding EXUBERA, Pfizer's inhaled Insulin, visit http://www.exubera.com

JANUVIA - a once-daily prescription pill that, along with diet and exercise, helps lower blood sugar levels in people with type 2 diabetes. It's a type of prescription diabetes medicine called a DPP-4 inhibitor (blocker). DPP-4 blockers enhance the body's own ability to control blood sugar levels.

For more information about Januvia, visit http://www.januvia.com.
Learn More About Participation
If you are interested in learning more about clinical trials for the treatment of diabetes or have any questions, you may click on the submit button at the bottom of this page. This submission will lead you to a secure form that will be sent to our center. We will then contact you via phone to discuss potential study participation. If you prefer, you may contact us directly by phone at 972-566-5678. If you or someone interested prefers to speak in Spanish, please call 972-566-5002.

Dallas Diabetes & Endocrine Center  |  7777 Forest Lane, Suite C-685  |  Dallas, TX 75230  |  972.566.7799
Copyright 2007 © Bryte Software Deisgn All right reserved.  |  Designed by Bryte Software Design